BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30718242)

  • 1. Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients.
    Sopfe J; Pyle L; Keating AK; Campbell K; Liu AK; Wadwa RP; Verneris MR; Giller RH; Forlenza GP
    Blood Adv; 2019 Feb; 3(3):350-359. PubMed ID: 30718242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic variability is associated with poor outcomes in pediatric hematopoietic stem cell transplant patients.
    Sopfe J; Campbell K; Keating AK; Pyle L; Liu AK; Verneris MR; Giller RH; Forlenza GP
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28626. PubMed ID: 33480469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composite Metric of Glycemic Control Q-Score Is Elevated in Pediatric and Adolescent/Young Adult Hematopoietic Stem Cell Transplant Recipients.
    Cho S; Vigers T; Pyle L; Franklin A; Sopfe J; Jeney F; Forlenza G
    Diabetes Technol Ther; 2023 Feb; 25(2):116-121. PubMed ID: 36511871
    [No Abstract]   [Full Text] [Related]  

  • 4. The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients.
    Hammer MJ; Casper C; Gooley TA; O'Donnell PV; Boeckh M; Hirsch IB
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):344-51. PubMed ID: 19203725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Accuracy of Factory-Calibrated Continuous Glucose Monitoring in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation.
    Sopfe J; Vigers T; Pyle L; Giller RH; Forlenza GP
    Diabetes Technol Ther; 2020 Oct; 22(10):727-733. PubMed ID: 32105513
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombotic and hemorrhagic complications in children and young adult recipients of Hematopoietic Stem Cell Transplant (HSCT).
    Kaur D; Ashrani AA; Pruthi R; Khan SP; Bailey K; Rodriguez V
    Thromb Res; 2018 Jul; 167():44-49. PubMed ID: 29787942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and outcomes of cytomegalovirus viremia in pediatric hematopoietic stem cell transplantation patients.
    Wu JL; Ma HY; Lu CY; Chen JM; Lee PI; Jou ST; Yang YL; Chang HH; Lu MY; Chang LY; Huang LM
    J Microbiol Immunol Infect; 2017 Jun; 50(3):307-313. PubMed ID: 26346369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.
    Ahmed I; Teruya J; Murray-Krezan C; Krance R
    Pediatr Transplant; 2015 Jun; 19(4):391-8. PubMed ID: 25809012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
    Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics.
    Keklik F; Alrawi EB; Cao Q; Bejanyan N; Rashidi A; Lazaryan A; Arndt P; Dincer EH; Bachanova V; Warlick ED; MacMillan ML; Arora M; Miller J; Brunstein CG; Weisdorf DJ; Ustun C
    Haematologica; 2018 Dec; 103(12):2109-2115. PubMed ID: 30076172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks and outcomes of invasive fungal infections in pediatric allogeneic hematopoietic stem cell transplant recipients receiving fluconazole prophylaxis: a multicenter cohort study by the Turkish Pediatric Bone Marrow Transplantation Study Group.
    Hazar V; Karasu GT; Uygun V; Öztürk G; Kiliç SÇ; Küpesiz A; Daloglu H; Aksoylar S; Atay D; Ince EÜ; Karakükçü M; Özbek N; Tayfun F; Kansoy S; Özyürek E; Akçay A; Gürsel O; Haskologlu S; Kaya Z; Yilmaz S; Tanyeli A; Yesilipek A
    Med Mycol; 2019 Feb; 57(2):161-170. PubMed ID: 29608706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluid balance of pediatric hematopoietic stem cell transplant recipients and intensive care unit admission.
    Benoit G; Phan V; Duval M; Champagne M; Litalien C; Merouani A
    Pediatr Nephrol; 2007 Mar; 22(3):441-7. PubMed ID: 17123119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors associated with liver injury and impact of liver injury on transplantation-related mortality in pediatric recipients of allogeneic hematopoietic stem cell transplantation.
    Radhakrishnan K; Bishop J; Jin Z; Kothari K; Bhatia M; George D; Garvin JH; Martinez M; Ovchinsky N; Lobritto S; Elsayed Y; Satwani P
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):912-7. PubMed ID: 23467127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, etiology, and risk factors for liver dysfunction in children following hematopoietic stem cell transplantation.
    Subbarao G; Haut PR; Johnson CS; Gowan D; Molleston JP
    Pediatr Transplant; 2006 Sep; 10(6):682-9. PubMed ID: 16911491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
    Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence and impact of dextrose dose on hyperglycemia from parenteral nutrition (PN) exposure in hematopoietic stem cell transplant (HSCT) recipients.
    Sheean P; Braunschweig C
    JPEN J Parenter Enteral Nutr; 2006; 30(4):345-50. PubMed ID: 16804133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurologic complications after allogeneic hematopoietic stem cell transplantation in children: analysis of prognostic factors.
    Kang JM; Kim YJ; Kim JY; Cho EJ; Lee JH; Lee MH; Lee SH; Sung KW; Koo HH; Yoo KH
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1091-8. PubMed ID: 25708217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
    Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malglycemia in the critical care setting. Part III: Temporal patterns, relative potencies, and hospital mortality.
    Roberts GW; Krinsley JS; Preiser JC; Quinn S; Rule PR; Brownlee M; Umpierrez GE; Hirsch IB
    J Crit Care; 2024 Jun; 81():154537. PubMed ID: 38364665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bloodstream infection after stem cell transplantation in children with idiopathic aplastic anemia.
    Kobayashi R; Yabe H; Kikuchi A; Kudo K; Yoshida N; Watanabe K; Muramatsu H; Takahashi Y; Inoue M; Koh K; Inagaki J; Okamoto Y; Sakamaki H; Kawa K; Kato K; Suzuki R; Kojima S
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1145-9. PubMed ID: 24727336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.